- Published on
Infectious Disease and Microbiology: Helicobacter pylori Infection
Helicobacter pylori infection is a common chronic bacterial infection of the stomach and is the leading cause of gastritis, peptic ulcer disease, and an important risk factor for gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. It is a gram-negative, spiral-shaped, microaerophilic organism that colonizes the gastric mucosa and can persist for decades if untreated. Although many infected individuals remain asymptomatic, the organism is associated with significant gastrointestinal morbidity.
Epidemiologically, H. pylori infects more than half of the global population, with a much higher prevalence in developing countries compared to industrialized nations. In developed regions such as the United States, prevalence is approximately 30%, increasing with age, whereas in developing countries it may reach up to 80%, often beginning in childhood. Risk factors are largely related to socioeconomic conditions, including poor sanitation, crowded living environments, and lack of access to clean water. Infection is usually acquired in early childhood and spreads primarily through person-to-person transmission via oral–oral or fecal–oral routes.
The pathophysiology of H. pylori infection is centered on its ability to survive in the acidic gastric environment through the production of urease, which converts urea into ammonia, thereby neutralizing gastric acid. The bacterium colonizes the gastric mucosa, leading to chronic active gastritis characterized by inflammatory cell infiltration. Over time, this can result in mucosal damage, ulcer formation, intestinal metaplasia, and in some cases, malignant transformation. Certain bacterial strains, such as those expressing cytotoxin-associated gene A (cagA), and host genetic factors increase the risk of severe disease.
Clinically, most patients with H. pylori infection are asymptomatic. When symptoms occur, they are usually related to dyspepsia, including upper abdominal pain, bloating, early satiety, and nausea. Alarm features such as weight loss, gastrointestinal bleeding, anemia, persistent vomiting, or progressive dysphagia raise concern for more serious conditions such as peptic ulcer disease or malignancy and require prompt evaluation.
Diagnosis can be made using invasive or non-invasive methods. Non-invasive tests include the urea breath test and fecal antigen test, both of which have high sensitivity and specificity and are commonly used for both diagnosis and confirmation of eradication. Serologic testing is less reliable due to its inability to distinguish between active and past infection. Invasive testing involves endoscopy with biopsy for urease testing, histology, or culture and is recommended in older patients or those with alarm symptoms. Certain medications, such as proton pump inhibitors and antibiotics, may reduce test accuracy and should be discontinued prior to testing.
Treatment of H. pylori infection involves combination therapy to achieve eradication and prevent complications. First-line regimens typically include a proton pump inhibitor combined with antibiotics such as clarithromycin and amoxicillin or metronidazole (triple therapy), or a bismuth-based quadruple regimen including bismuth, tetracycline, metronidazole, and acid suppression therapy. Treatment duration ranges from 10 to 14 days, and eradication rates are influenced by antibiotic resistance patterns. Second-line therapies include alternative antibiotic combinations such as levofloxacin-based regimens.
Follow-up is important to confirm eradication, particularly in patients with persistent symptoms, ulcers, MALT lymphoma, or a history of gastric cancer. Non-invasive tests such as the urea breath test or fecal antigen test are preferred for this purpose. Patient education should emphasize adherence to therapy, as incomplete treatment contributes to treatment failure and resistance.
The prognosis is generally favorable with successful eradication, which significantly reduces the risk of ulcer recurrence and complications. However, untreated infection may lead to chronic gastritis, peptic ulcer disease, gastric adenocarcinoma, and MALT lymphoma. Recurrence rates are low in developed countries but higher in areas with poor sanitation. Common treatment-related side effects include gastrointestinal upset and taste disturbances.
0 Comments
